Skin vascular disease
MONDO:0019293A disease that involves the superficial vasculature.
Also known as: skin vascular disorder, superficial vasculature disease, vascular disease of the skin, vascular skin disease, vasculature skin disease, disorder of blood vessels affecting skin, vascular disorder of skin, vascular disorders of skin
134 clinical trials for this condition and its sub-types, 5 tagged with Skin vascular disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Skin vascular disease
-
Angioedema 19 trials · 66 incl. sub-types
3 sub-types
- Hereditary angioedema 58 trials · 60 incl. sub-types Sub-types →
- Acquired angioedema 2 trials · 3 incl. sub-types Sub-types →
- Non-histaminic angioedema 2 trials
-
Behcet disease 37 trials
-
Familial multiple nevi flammei 12 trials
-
Livedo reticularis 3 trials
-
Chilblain lupus 1 trial · 3 incl. sub-types
1 sub-type
- Familial chilblain lupus 2 trials Sub-types →
-
Maffucci syndrome 2 trials
-
Sneddon syndrome 2 trials
-
Blue rubber bleb nevus 2 trials
-
Malignant atrophic papulosis 2 trials
-
Pityriasis lichenoides 1 trial
1 sub-type
-
Bockenheimer syndrome 0 trials
-
Cobb syndrome 0 trials
-
Wyburn-Mason syndrome 0 trials
-
Angioma serpiginosum 0 trials
2 sub-types
- Angioma serpiginosum, X-linked 0 trials
- Angioma serpiginosum, autosomal dominant 0 trials
-
Atrophic papulosis 0 trials
1 sub-type
- Benign atrophic papulosis 0 trials
-
Calciphylaxis cutis 0 trials
-
Cutaneous collagenous vasculopathy 0 trials
-
Generalized essential telangiectasia 0 trials
Most studied deeper sub-types
-
Could a daily pill stop hereditary angioedema attacks?
Disease control Stopped earlyThis trial tests whether an experimental oral medication, deucrictibant, can reduce the number of swelling attacks in people with hereditary angioedema (HAE) types I and II. Participants take either a low or high dose of the drug or a placebo for 12 weeks, and then may continue o…
Phase 2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Laser plus gel: new hope for port wine stains?
Disease control Stopped earlyThis study tested whether adding timolol gel to pulsed dye laser treatment could improve results for port wine stains on children's faces. Twenty-five children aged 6 months to 18 years were enrolled, but the study was stopped early. The goal was to see if the combination led to …
Phase 3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New daily pill aims to stop HAE attacks, but trial cut short
Disease control Stopped earlyThis phase 2 trial tested KVD824, an oral pill, to prevent swelling attacks in people with hereditary angioedema types I and II. The study planned to compare three doses against a placebo over several months. However, the trial was terminated early with only 33 participants, so t…
Phase 2 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental shot for Cold-Triggered hives tested, but trial stopped early
Symptom relief Stopped earlyThis early-stage trial tested a single dose of a drug called briquilimab in 27 adults with chronic hives caused by cold or friction that did not improve with standard allergy pills. The main goal was to check safety and see if the drug could reduce symptoms. However, the trial wa…
Phase 1/2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Scientists hunt for blood clues to tame unpredictable swelling attacks
Knowledge-focused Stopped earlyThis study aimed to find biomarkers (measurable substances in the blood) that could help doctors diagnose bradykinin angioedema and predict how severe attacks might be. The condition causes sudden, unpredictable swelling, and current tests don't work well for all types. Researche…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC